Novel Drug Targets Lymphoma Cells ' ' Don ' t Eat Me ' Signal Novel Drug Targets Lymphoma Cells ' ' Don ' t Eat Me ' Signal

The first-in-class agent Hu5F9 is a macrophage immune checkpoint inhibitor and, when added onto rituximab, shows potentially long-lasting efficacy in patients with relapsed and refractory lymphoma.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news